-
OPTIMIZING COMBINATION THERAPY AFTER TREATMENT FAILURE USING THE LATEST TECHNOLOGIES IN RESOURCE-LIMITED SETTINGS
May 01, 2023
-
DR 021: RISK FACTORS FOR HYPERTENSION EMERGING WITHIN ONE YEAR OF INITIATING ANTIRETROVIRAL THERAPY AMONG PEOPLE LIVING WITH HIV
Mar 01, 2023
-
BAMLANIVIMAB REDUCES NASAL VIRAL LEVELS AND INFLAMMATION BUT NOT SYMPTOM DURATION WHEN GIVEN FOR EARLY COVID-19 TREATMENT
Dec 01, 2022
-
COMPARING PHARMACOKINETICS OF INTRAVENOUS VS. INTRAMUSCULAR AZD7442 AMONG PARTICIPANTS WITH MILD-TO-MODERATE COVID-19
Dec 01, 2022
-
ADHERENCE TO ISONIAZID PREVENTIVE TB THERAPY REDUCES DEATH AND DEVELOPMENT OF ACTIVE TB AMONG ADULTS WITH ADVANCED HIV WHO ARE STARTING ART
Nov 01, 2022
-
GEOGRAPHICAL DIFFERENCES IN SELF-REPORTED FUNCTIONAL IMPAIRMENT OF PEOPLE LIVING WITH HIV
Oct 07, 2022
-
THIRD-LINE ART HAS POTENTIAL TO IMPROVE CARE FOR PEOPLE LIVING WITH HIV IN LOWER-TO-MIDDLE INCOME COUNTRIES
Oct 07, 2022
-
BEDAQUILINE IS ABLE TO PENETRATE THE BLOOD-CEREBROSPINAL FLUID BARRIER, MAY HOLD POTENTIAL FOR TREATMENT OF TB MENINGITIS
Oct 01, 2022
-
ASYMPTOMATIC SARS-COV-2 INFECTION IS EXTREMELY COMMON AMONG PEOPLE WITH HIV
JAIDS, August 2022.
Sep 08, 2022
-
THE MOXIE TRIAL SHOWS THAT WOMEN ARE INVESTED IN CURE RESEARCH
Clinical Infectious Diseases, February 2022.
Sep 08, 2022
-
CARDIOVASCULAR RISK AND HEALTH AMONG PEOPLE WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) ELIGIBLE FOR PRIMARY PREVENTION: INSIGHTS FROM THE REPRIEVE TRIAL
Clinical Infectious Diseases, December 2021.
Dec 01, 2021
-
ASSESSING THE RELATIONSHIP BETWEEN GREATER MUSCLE FAT AND LOWER MUSCLE AREA AND INFLAMMATION AND IMMUNE ACTIVATION AFTER STARTING ART
JAIDS, August 5, 2021.
Oct 06, 2021
